Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537254 | PMC |
| http://dx.doi.org/10.1002/bjs.11994 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of SARS-CoV-2 variants on viral infectivity and the role of the renin-angiotensin-aldosterone system.
Hypertens Res
January 2025
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Balance between Protective vs. Exacerbating Effects of ACEIs and ARBs in Omicron Variant Infections. The spike protein on the surface of the Omicron variant has a high affinity for ACE2, making it more prone to enter cells and induce ACE2 downregulation.
View Article and Find Full Text PDFPredicting User Engagement in Health Misinformation Correction on Social Media Platforms in Taiwan: Content Analysis and Text Mining Study.
J Med Internet Res
January 2025
Institute of Learning Sciences and Technologies, National Tsing Hua University, Hsinchu, Taiwan.
Background: Health misinformation undermines responses to health crises, with social media amplifying the issue. Although organizations work to correct misinformation, challenges persist due to reasons such as the difficulty of effectively sharing corrections and information being overwhelming. At the same time, social media offers valuable interactive data, enabling researchers to analyze user engagement with health misinformation corrections and refine content design strategies.
View Article and Find Full Text PDFSustainable performance evaluation of pharmaceutical companies: sustainable balanced scorecard and hybrid MCDM approach.
Front Public Health
January 2025
College of Economics and Management, Nanjing University of Science and Technology, Nanjing, Jiangsu, China.
Despite the increasing demand for sustainable development of pharmaceutical companies due to the rigorous pressure of environmental regulation, public health crisis and economic competition, there has been little research on relevant evaluation models. The COVID-19 experience has also prompted investors in pharmaceutical companies to re-examine the impact of environment and ethics on business development. Therefore, pharmaceutical companies need to focus on their performance, especially on the shift from a single financial performance to an integrated performance.
View Article and Find Full Text PDFA retrospective view of hospital pharmacy in the UK over the last 20 years.
Future Healthc J
December 2024
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
In this article, we describe how the landscape of hospital pharmacy has changed over the last 20 years. As well as commenting on the impact of COVID-19 on services, we describe five major advancements namely: clinical pharmacy services, the development of multi-professional teams, policy changes, attitudes to using and producing evidence, advances in technology and workforce development. Finally, there is brief comment around the future challenges for hospital pharmacy in the UK.
View Article and Find Full Text PDFComment on the Article: Exaggerated immune response to fungal keratitis post-COVID19 vaccination.
Asia Pac J Ophthalmol (Phila)
January 2025
Ophthalmology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!